- Winter 2013Noven Pharms., Inc. v. Watson Labs., Inc.
- IP: Is Inter Partes Review an Improvement Over Inter Partes Reexam?
- Winter 2013Auxilium Pharms., Inc. v. FCB I LLC
- Winter 2013AstraZeneca AB v. Apotex Corp.
- Winter 2013ViiV Healthcare UK Ltd. v. Lupin Ltd.
- Winter 2013Cephalon, Inc. v. Sun Pharms., Ltd.
- Winter 2013AstraZeneca LP v. Breath Ltd.
- Winter 2013Cadence Pharms., Inc. v. Exela Pharms. Sciences, LLC
- Winter 2013The Medicines Co. v. Mylan, Inc.
- Winter 2013Galderma Labs., L.P. v. Tolmar, Inc.
- Winter 2013Prometheus Labs. Inc. v. Roxane Labs., Inc.
- Winter 2013Fresenius USA, Inc. v. Baxter International, Inc.
- Winter 2013Insite Vision Inc. v. Sandoz Inc.
- Winter 2013AstraZeneca AB v. Hanmi USA, Inc.
- Winter 2013Auxilium Pharms., Inc. v. Upsher-Smith Laboratories, Inc.
- Winter 2013Novartis Pharma. Corp. v. Wockhardt USA LLC
- January 21, 2014High Bar for 'Natural' Class, Despite FDA Ambiguity
- January 16, 2014Why More Rule Amendments?
- Winter 2013ANDA Litigation Settlements
- Winter 2013New ANDA Cases
- Winter 2013ANDA Approvals
- Winter 2013
- IP: 3D Printing Patent Litigation Now: The Shape of Things to Come?
- Court Split Over Contra Proferentem Doctrine Widens
- Stryker® Orthopedics Recalls its Rejuvenate® and ABG™ II Modular-Neck Hip Stems
- For My Appellate Christmas Stocking
- December 19, 2013Day of Reckoning for Securities Class Actions
- IP: Thinking Ahead about 3D Printing
- IP: 3D Printing Can Create Trade Secrets Misappropriation Opportunities
- From the Computer to the Courtroom: The Evolving Role of Source Code in Complex Trials
- Fifteen Things to Expect from the SEC’s Enforcement Division in 2014
- No Coverage For Fraudulent Withdrawal Of Electronic Funds
- December 4, 2013Emerging Trend Against Nationwide Venue in Antitrust Cases
- IP: 3D Scanners, IP Issues with Additive Printing’s Companion Technology
- What I Really Meant to Say Was …
- IP: Five 3D Printing Headlines and the Law Issues They Raise
- When Fire Strikes the Surgical Suite
- November 7, 2013Anticipating a FINRA Arbitration – What’s Next?
- Bad News For Apple, Great News For Patent Owners
- November 5, 2013Third-Party Litigation Investing And Attorney-Client Privilege
- November 4, 2013Litigating Attorneys Fee Claims Proving Reasonableness and Rates of Attorneys Fees and Costs
- An Interview with the Lawyer Who Discovered Clarence Darrow’s Letters
- IP: 3D Printing and Potential Patent Infringement
- 4 Discovery Strategies for Cases Involving Source Code
- October 25, 2013Where Does a Fresh Start End?
- November 25, 20135 Avoidable Pitfalls in Source Code Discovery
- Ignore Technology at your own Peril
- October 21, 2013"Loss of Chance" Claims
- Fall 2013ANDA Approvals
- Fall 2013Purdue Pharma L.P. v. Ranbaxy Inc.